Certain information set forth in this presentation contains "forward-looking information", including, but not limited to, "potential penetration statements” and "assumptions", under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, all information contained herein constitutes forward-looking statements and includes, but is not limited to, the expected development of MMH's business.

These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements.

There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. MMH undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change. The reader is cautioned not to place reliance on forward-looking statements.

MMH makes no representation or warranty to any prospective investor with respect to the forward-looking statements. With respect to these statements made available by or on behalf of MMH to prospective investors, each prospective investor acknowledges that: (a) there are uncertainties inherent in attempting to make such statements, (b) such investor is familiar with such uncertainties, (c) such investor takes full responsibility for making its own evaluation of the adequacy and accuracy of all information provided, and (d) prospective investors shall have no claim against MMH, including its officers, directors and legal and financial representatives, whatsoever based upon the inaccuracy of any information contained in this document.

The musculoskeletal (MSK) health market has proven to be one of the fastest-growing sectors in digital health, with several platforms reaching multi-billion-dollar valuations.

While many companies in this space focus on high-barrier channels such as insurers and large employers, MyMedicalHub (MMH) takes a unique approach — proving value first through direct-to-consumer, athlete, and veteran populations.

Our AI-driven assessments, longitudinal health tracking, and digital therapeutics can be accessed from any smart device — empowering users, providers, and institutions to make more informed decisions and drive better outcomes.

MMH’s ability to scale across B2C, B2B, and government channels simultaneously — supported by patented technology and a modular architecture — positions the platform for rapid adoption and long-term impact.